î ƒ

Keeping it Real: Patient Engagement in Evidence Generation

In this webinar, we will discuss the regulatory bodies such as the Food and Drug Administration (FDA) and European Medicines Agency (EMA) are increasingly recognising the value of supplementing clinical trial data with real-world evidence to improve understanding of drug performance in the healthcare setting.

How pre-launch scientific activities are associated with launch success

Experts from Pfizer and Veeva explore a recent Veeva Pulse Report showing that targeted scientific outreach is associated with 40% faster treatment adoption.

Regional Considerations and Challenges in Integrated Evidence Generation Planning (IEGP) 

In this podcast, experts explore the many challenges associated with the operationalization of global Integrated Evidence Generation Planning (IEGP) at local levels. 

Putting the AI into Innovative Medical Affairs Teams

In this webinar, we will share a comprehensive and practical overview of how Artificial Intelligence (AI) can be integrated into various functions of Medical Affairs.

Top 10 Most “Interesting” Publications of 2024

What makes a publication interesting or impactful? Is it number of citations? Sentiment among important stakeholders? Relevance to the largest patient population? Popular news attention? The answer depends on your strategy. Here we speak with experts from Altmetric about 10 publications that are impactful for different reasons.

The Changing Landscape of Journal Performance Measurement

Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.

Measuring the Impact of Medical Affairs – Part 2: Building a strong foundation of operational effectiveness

Dig into best practices for measuring the operational effectiveness of Medical Affairs teams, emphasizing the importance of establishing a strong foundation of data and metrics to demonstrate impact and value within pharmaceutical organizations.

Measuring the Impact of Medical Affairs: A data-driven modular approach

In this webinar, we will share new data showing that while medical affairs is increasing in importance, it is still struggling to reach a consensus around medical impact metrics. However, measuring medical impact is no longer a choice; it’s a necessity for medical to communicate its value as a business function and better demonstrate its contributions to successful patient outcomes.

2024 Benchmark Report: Digital, Advanced Analytics & Artificial Intelligence in Medical Affairs

MAPS' 2024 Benchmark Report is based on findings from 32 organizations in Pharma and MedTech and reflects broad leadership thinking about the current and future states of AI capabilities and challenges in Medical Affairs.